The Deep End

The Deep End

The Deep End by On Deck is a podcast where visionary builders, creators, and experts discuss world-changing ideas. We skip the surface level and go in depth into ideas that matter including the futures of commerce, higher education, art, governance, longevity, and more with some of the most exciting figures in these fields. The Deep End is hosted by Marshall Kosloff and produced by On Deck—where top talent go to accelerate their ideas and careers. Visit ideas.beondeck.com for show notes and additional essays.

Recent Episodes

Sept. 30, 2024

Eoghan McCabe: moving to America to build Intercom into a unicorn + the benefits of naivety, hard work, and rejection.

Eoghan (CEO and co-founder of Intercom) joins ODF for a wide-ranging conversation about his experiences building a successful startup in San Francisco and his advice for other founders.
Feb. 12, 2024

Deep Dive: Find the right co-founder and idea with Mo El Mahallawy, CTO and co-founder of Shepherd

Discussion focused on finding your co-founder and navigating the idea maze.
Feb. 6, 2024

Deep Dive: Shutting down a startup, doing right by your team, and founder identity with Stevie Cline (VC at Vol. 1 Ventures)

Deep Dive with Stevie Cline (ODF4) — managing partner at Vol. 1 Ventures — on shutting down startups, founder identity, and the long arc of ambition. Prior to VC, Stevie was a partner at a major law firm and her blog Highly …
Jan. 19, 2024

Control Your Financial Destiny: Runway, Metrics, and more with Puzzle's CEO Sash Orloff

Sasha Orloff is the co-founder and CEO of Puzzle, a company that builds modern accounting software specifically for startups.
Dec. 7, 2023

Augmenting people with AI and building the future featuring Matt Rastovac of Respell

Matt Rastovac is the founder of Respell, a company that builds AI-powered workflows and agents to assist on tasks enabling individuals and teams can be more effective than ever before.
Dec. 2, 2023

"The most important milestone in the history of longevity biotech" — Archival Interview with Celine Halioua (Founder/CEO of Loyal)

Loyal (ODF2) has earned what they believe to be the FDA’s first-ever formal acceptance that a drug can be developed and approved for lifespan extension. Truly groundbreaking. You’re about to listen to an archival interview w…